Kuangda Technology Group (002516.SZ) plans to invest in establishing a subsidiary in Zhuzhou to undertake localized production and services in the region.
Kuangda Technology (002516.SZ) announced that the company plans to invest 50 million yuan to establish a wholly-owned subsidiary in Tianyuan District, Zhuzhou City (hereinafter referred to as "Zhuzhou Subsidiary"). The core positioning of the establishment of the Zhuzhou Subsidiary this time is to serve as the core business support point of the company in the Central China region, undertaking regional production and services, and being responsible for the pilot and industrialization of emerging business lines.
Kuangda Technology Group (002516.SZ) announced that the company plans to invest 50 million yuan to establish a wholly-owned subsidiary in Tianyuan District, Zhuzhou City (hereinafter referred to as "Zhuzhou Subsidiary"). The core positioning of the Zhuzhou Subsidiary is to serve as the company's core business support point in the Central China region, undertaking localized production and services, and responsible for piloting and industrializing emerging business lines.
By establishing the Zhuzhou Subsidiary, the company aims to fill the production capacity gap in the Central China region, optimize the national production layout, enhance service efficiency for core customers, and increase market share. It also aims to cultivate high value-added emerging business clusters to build long-term growth momentum for the company. Through deepening industrial ecosystem collaboration, the company aims to align its overall strategy with market demand and industry trends, laying a solid foundation for its long-term development.
Related Articles

LEGEND STRAT (01355) intends to acquire 100% of the issued share capital of Ohno Hong Kong.

REGO INTERACT (02422) proposes to discount about 19.44% for the sale of up to 160 million shares, with a net fundraising of approximately 68.6 million Hong Kong dollars.

Legend Strat (01355) is intended to be renamed "Biological Systems Engineering Limited Company."
LEGEND STRAT (01355) intends to acquire 100% of the issued share capital of Ohno Hong Kong.

REGO INTERACT (02422) proposes to discount about 19.44% for the sale of up to 160 million shares, with a net fundraising of approximately 68.6 million Hong Kong dollars.

Legend Strat (01355) is intended to be renamed "Biological Systems Engineering Limited Company."

RECOMMEND





